Morning-Outlook-Feature-Image
Outlook

NIFTY:

Nifty opened at 16723.20 wit ha gap up of 118 points. Initial prices moved higher but the rally did not sustain lo ng as prices have moved down after recording its intraday high at 16768.95. The index drifted downwards, filled the up gap very quickly, and kept on sliding lower. A sharp decline of more than 300 points from the highs brought prices to its intraday low at 16442.95. Prices have seen minor rallies in between but bulls do not have enough strength today and the index keeps on moving down to finally closed at 16498.05 wit ha loss of 107.90 points or 0.65% down. IT, METAL, and OIL GAS outperformed today and closed wit h a ga in of more than 1%.BANK, FINANCIAL ,and AUTO under performed today and ended wit ha loss of more than 1%.

The index traded in a wide range today. The Volatility remained very high as the volatility index ‘INDIA VIX’ is moving around 28. It will be normal when the index moves below 18. As mentioned yesterday, “The chances of a low volatile environment are less at least for this week due to the Russia-Ukraine issue ‘Support is visible around first at 16200, if breach then 15500. Strong resistance is visible inside the 16800 – 16900 range. The index attempted to break 16800 resistance today but failed to do it. We are in an environment of fear & uncertainty. In such an environment we should step aside and not indulge ourselves in any kind of trading.

BANK NIFTY:

BANK NIFTY opened at 35621.15 wit h a gap up of 147 points. The index recorded its intraday high at 35804.15 and then moved on the downside. The index filled the gap quickly, fell more than 100 points intraday and recorded its intraday low at 34721.15. The index consolidated in the last hour of trading and finally closed at 34966.10 with a loss of 508 points. PVT and PSU BANKS have performed almost same today, saw an intraday decline and ended with a loss of 1.03% and 0.71% respectively. We are tracking pattern of bearish Head & Shoulder with the short-term trend is down as index made lower lows. We should avoid trading the index and wait markets to stabilize first. Resistance is visible around 36800. Support is visible around 34000.

TECHNICAL PICKS

COMPANY NAME CMP B/S RATIONALE+
WIPRO 569 BUY The stock is on the verge of giving the breakout on the intraday as well as the daily chart. The stock can be bought  with a stop loss of 560 and for the target of 580.
INDIAMART 4547 SELL The  immediate trend of the script is bearish. There is a negative  cross over of moving averages  as well as of the indicators therefore  it can be sell below 4545 with a stop loss of 4580 and target  of 4340.

DERIVATIVE PICKS

COMPANY NAME CMP B/S RATIONALE+
WIPRO 569 BUY The stock is on the verge of giving the breakout on the intraday as well as the daily chart. The stock can be bought  with a stop loss of 560 and for the target of 580.
INDIAMART 4547 SELL The  immediate trend of the script is bearish. There is a negative  cross over of moving averages  as well as of the indicators therefore  it can be sell below 4545 with a stop loss of 4580 and target  of 4340.
Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
HEROMOTOCO.Mar 31 2430 0.01 8.04 3549000 GUJGASLTD.Mar 31 525.1 -7.36 21.11 2897500
TCS.Mar 31 3554.95 0.07 2.42 13329300 ASHOKLEY.Mar 31 110.05 -6.93 9.57 46791000
TORNTPOWER.Mar 31 480.4 0.08 0.41 3315000 UBL.Mar 31 1397.95 -6.89 17.7 1091300
MPHASIS.Mar 31 3156.85 0.11 5.28 1679125 ULTRACEMCO.Mar 31 5991.25 -6.69 46.28 3211900
ADANIENT.Mar 31 1649.9 0.16 0.13 20423500 ESCORTS.Mar 31 1674 -6.6 11.4 4111800
                                                                        Short Covering                                                                       Long Unwinding
HONAUT.Mar 31 40644.9 0.26 -1.48 7005 NBCC.Mar 31 38.5 -2.16 -1.13 23004000
GNFC.Mar 31 585.9 0.59 -0.28 2736500 LALPATHLAB.Mar 31 2447.45 -1.84 -1.65 825500
DELTACORP.Mar 31 265.8 0.95 -0.26 13135300 IDFC.Mar 31 56.2 -1.58 -0.02 80770000
INDUSTOWER.Mar 31 211 1.64 -0.62 23601200 BALKRISIND.Mar 31 1801.3 -0.41 -0.39 1482400
NATIONALUM.Mar 31 128.85 2.3 -0.7 92429000 HAL.Mar 31 1387 -0.37 -1.35 1945600

TOP DELIVERY PERCENTAGE

Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
Godrej Cons Products Ltd 733.8 -2.46 2003112 0 76.84 Nifty50 16498.05 -0.65 85065
Icici Lombard General In 1240.55 -0.88 507149 0 76.52 Niftybank 34944.3 -1.21 85065
Hdfc Ltd. 2273 -0.22 6191711 0 73.79 Nifty it 34130.3 1.22 85065
Hdfc Bank Ltd. 1371 -0.24 8763961 0 70.6 Nifty Auto 10261.1 -2.28 85065
Hcl Technologies Ltd. 1139.7 2.16 3969380 0 70.51 Nifty Metal 6210.25 1.2 85065
Infosys Limited 1720.85 1.06 7344147 0 69.02 India Vix 28.16 -3.66 85065
Larsen & Toubro Limited 1752.3 -1.8 2259979 0 67.19 Nifty Realty 429 -0.52 85065
Hindustan Unilever Ltd 2091 -2.7 2372998 0 66.85 Nifty Fmcg 35019.6 -0.98 85065
Britannia Ind Ltd. 3366.4 -0.75 429892 0 66.33 Nifty Media 2056.15 0.39 85065
City Union Bank Ltd. 119.6 -0.66 4508362 0 65.28 Nifty Pharma 12643.75 -0.36 85065
Nifty Financial Services 16359.05 -1.17 85065

UPCOMING ECONOMIC DATA

   Domestic                                                                                                                                                  International
INR: Nikkei Services PMI (Feb) on 4th March, 2022

INR: FX Reserves, USD on 4th March, 2022

•USD:  Unemployment Rate (Feb) on 4rd March, 2022

•USD:  Nonfarm Payrolls (Feb) on 4th March, 2022

NEWS UPDATES

  • The financial sBatteries and flashlights maker Eveready Industries India Ltd on Thursday said its Non-Executive Chairman Aditya Khaitan and Managing Director Amritanshu Khaitan have resigned following an open offer from the Burman group. The Burman group, through various entities had on Monday made a Rs 604.76-crore open offer to acquire around 1.89 crore shares of Eveready Industries, representing 26 per cent of the expanded voting share capital, at a price of Rs 320 per share, payable in cash
  • Drug major Lupin on Thursday said it has received approval from the US health regulator to market Efinaconazole topical solution, used to treat fungal toenail infections, in the American market. The company has received approval from the United States Food and Drug Administration (FDA) to market the generic version of Bausch Health Americas’ Jublia topical solution, the Mumbai-based drug maker said in a regulatory filing.
  • UPL Ltd on Thursday said it will sell 49.98 per cent equity in its non-operational subsidiary firm Agri Net Solutions Ltd (ANSL) to promotor group entity Nerka Chemicals for Rs 1.75 crore. UPL, in a regulatory filing, said it will offload the stake for a consideration of Rs 1.75 crore and the deal is expected to be completed by March 31 this year.
  • MG Motor India on Thursday announced a new venture, MG Charge, to build charging infrastructure for electric vehicles with an aim to install 1,000 chargers in residential areas across India in 1,000 days. As part of the initiative, the company will install 1,000 AC fast, type 2 chargers, a more commonly used type of charger for electric vehicles, supporting most of the leading current and future EVs, MG Motor India said in a statement.

Source: Economic Times,  Indian Express  ,Business Today, Livemint, Business Standard, Bloomberg Quint.

BOARD MEETINGS

Company Name Purpose Ex-Date Company Name Purpose Ex-Date
ADVIKCA Right Issue of Equity Shares;General 04-Mar-22 TVSELECT Interim Dividend 05-Mar-22
NAZARA Preferential Issue of shares 04-Mar-22 VARIMAN Preferential Issue of shares;Stock  Split 05-Mar-22
NMSRESRC General 04-Mar-22 MAL General 06-Mar-22
NNTL Preferential Issue of shares 04-Mar-22 AAVAS General 07-Mar-22
RUBRAME General 04-Mar-22 GANESHBE General 07-Mar-22
UBEINDL General 04-Mar-22 KCLINFRA Right Issue of Equity Shares 07-Mar-22
CONTCHM General 05-Mar-22 METROBRAND Interim Dividend;General 07-Mar-22
IFL In. in Auth. Capital;Warrants;Pref. Issue 05-Mar-22 NLCINDIA Interim Dividend 07-Mar-22
SABOOBR General 05-Mar-22 PRECISION General 07-Mar-22
SAGL Amalgamation;Scheme of Arrangement 05-Mar-22 RAINBOWF General;Rights Issue 07-Mar-22
SANINFRA General 05-Mar-22 SHREEGANES Bonus issue 07-Mar-22
SRTRANSFIN Interim Dividend 05-Mar-22 SUNTV Interim Dividend 07-Mar-22
SWANENERGY General;Preferential Issue of shares 05-Mar-22 TRADWIN A.G.M.;Audited Results;Quarterly Results 07-Mar-22

CORPORATE ACTION

Company Name Ex-Date Purpose Company Name Ex-Date Purpose
JAYSHREETEA 07-Mar-22 E.G.M. EIDPARRY 10-Mar-22 Interim Dividend – Rs. – 5.5000
NOUVEAU 07-Mar-22 Stock  Split From Rs.10/- to Rs.1/- MUL 10-Mar-22 Stock  Split From Rs.10/- to Rs.1/-
DEEP 08-Mar-22 Bonus issue 3:4 ULTRACAB 10-Mar-22 Stock  Split From Rs.10/- to Rs.2/-
VIPIND 08-Mar-22 Interim Dividend – Rs. – 2.5000 ULTRACAB 10-Mar-22 Bonus issue 1:2
VEDL 09-Mar-22 Interim Dividend – Rs. – 13.0000 VISHAL 10-Mar-22 Bonus issue 2:1
7TEC 10-Mar-22 Interim Dividend – Rs. – 1.0000 SRTRANSFIN 11-Mar-22 Interim Dividend
BCLENTERPR 10-Mar-22 Bonus issue 1:1 DICIND 14-Mar-22 Final Dividend – Rs. – 3.0000
BCLENTERPR 10-Mar-22 Stock  Split From Rs.10/- to Rs.1/- DICIND 14-Mar-22 Special Dividend – Rs. – 2.0000

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL